BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 23932219)

  • 1. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.
    Allen SJ; Wareham K; Wang D; Bradley C; Hutchings H; Harris W; Dhar A; Brown H; Foden A; Gravenor MB; Mack D
    Lancet; 2013 Oct; 382(9900):1249-57. PubMed ID: 23932219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE).
    Allen SJ; Wareham K; Wang D; Bradley C; Sewell B; Hutchings H; Harris W; Dhar A; Brown H; Foden A; Gravenor MB; Mack D; Phillips CJ
    Health Technol Assess; 2013 Dec; 17(57):1-140. PubMed ID: 24309198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial.
    Hickson M; D'Souza AL; Muthu N; Rogers TR; Want S; Rajkumar C; Bulpitt CJ
    BMJ; 2007 Jul; 335(7610):80. PubMed ID: 17604300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre randomised controlled trial evaluating lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea in older people admitted to hospital: the PLACIDE study protocol.
    Allen SJ; Wareham K; Bradley C; Harris W; Dhar A; Brown H; Foden A; Cheung WY; Gravenor MB; Plummer S; Phillips CJ; Mack D
    BMC Infect Dis; 2012 May; 12():108. PubMed ID: 22559011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.
    Chatterjee S; Kar P; Das T; Ray S; Gangulyt S; Rajendiran C; Mitra M
    J Assoc Physicians India; 2013 Oct; 61(10):708-12. PubMed ID: 24772726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
    Pozzoni P; Riva A; Bellatorre AG; Amigoni M; Redaelli E; Ronchetti A; Stefani M; Tironi R; Molteni EE; Conte D; Casazza G; Colli A
    Am J Gastroenterol; 2012 Jun; 107(6):922-31. PubMed ID: 22472744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial.
    Selinger CP; Bell A; Cairns A; Lockett M; Sebastian S; Haslam N
    J Hosp Infect; 2013 Jun; 84(2):159-65. PubMed ID: 23618760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial.
    Cornely OA; Crook DW; Esposito R; Poirier A; Somero MS; Weiss K; Sears P; Gorbach S;
    Lancet Infect Dis; 2012 Apr; 12(4):281-9. PubMed ID: 22321770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review.
    Xie C; Li J; Wang K; Li Q; Chen D
    Travel Med Infect Dis; 2015; 13(2):128-34. PubMed ID: 25805164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
    McFarland LV
    Am J Gastroenterol; 2006 Apr; 101(4):812-22. PubMed ID: 16635227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial.
    Zanger P; Nurjadi D; Gabor J; Gaile M; Kremsner PG
    Lancet Infect Dis; 2013 Nov; 13(11):946-54. PubMed ID: 24012319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Johnston BC; Supina AL; Ospina M; Vohra S
    Cochrane Database Syst Rev; 2007 Apr; (2):CD004827. PubMed ID: 17443557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients.
    Gao XW; Mubasher M; Fang CY; Reifer C; Miller LE
    Am J Gastroenterol; 2010 Jul; 105(7):1636-41. PubMed ID: 20145608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACP Journal Club. A microbial preparation did not reduce diarrhea in older inpatients receiving antibiotics.
    Ferrada M; O'Grady NP
    Ann Intern Med; 2013 Nov; 159(10):JC9. PubMed ID: 24247699
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multicenter, randomized, controlled clinical trial on preventing antibiotic-associated diarrhea in children with pneumonia using the live Clostridium butyricum and Bifidobacterium combined Powder].
    Investigating Group for Prevention of AAD in Children with Pneumonia by Clostridium Butyricum and Bifidobacterium
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):732-6. PubMed ID: 23302558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis: probiotics in antibiotic-associated diarrhoea.
    Videlock EJ; Cremonini F
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1355-69. PubMed ID: 22531096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
    Łukasik J; Szajewska H
    BMJ Open; 2018 Jun; 8(5):e021214. PubMed ID: 29866789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.
    Gerding DN; Meyer T; Lee C; Cohen SH; Murthy UK; Poirier A; Van Schooneveld TC; Pardi DS; Ramos A; Barron MA; Chen H; Villano S
    JAMA; 2015 May; 313(17):1719-27. PubMed ID: 25942722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic-associated diarrhea: a refresher on causes and possible prevention with probiotics--continuing education article.
    Varughese CA; Vakil NH; Phillips KM
    J Pharm Pract; 2013 Oct; 26(5):476-82. PubMed ID: 24064436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics for antibiotic-associated diarrhea: PLACIDE swings the pendulum.
    Rezaie A; Pimentel M
    Gastroenterology; 2014 Jun; 146(7):1822-3. PubMed ID: 24768591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.